1. Predictors of treatment success in children with difficult to treat atopic dermatitis using a personalized integrative multidisciplinary (PIM) treatment programme
- Author
-
Suzanne G.M.A. Pasmans, Renske Schappin, Karin B. Fieten, Lucia H. Rijssenbeek-Nouwens, Yolanda Meijer, Wieneke T. Zijlstra, University of Zurich, Fieten, K B, and Dermatology
- Subjects
Male ,Pediatrics ,Multivariate analysis ,Dermatitis ,Eczema Area and Severity Index ,Severity of Illness Index ,030207 dermatology & venereal diseases ,0302 clinical medicine ,10183 Swiss Institute of Allergy and Asthma Research ,Sickness Impact Profile ,Medicine ,Precision Medicine ,Child ,Dermatitis, Atopic/diagnosis ,Academic Medical Centers ,Medical record ,Dermatology Life Quality Index ,Precision Medicine/methods ,Clinical Trial ,Infectious Diseases ,Treatment Outcome ,Anxiety ,Female ,medicine.symptom ,Psychosocial ,medicine.medical_specialty ,Adolescent ,Dermatologic Agents/administration & dosage ,610 Medicine & health ,Dermatology ,Dermatitis, Atopic ,2708 Dermatology ,03 medical and health sciences ,Atopic/diagnosis ,Predictive Value of Tests ,030225 pediatrics ,Severity of illness ,Journal Article ,Humans ,business.industry ,Patient Selection ,2725 Infectious Diseases ,Clinical trial ,Logistic Models ,Multivariate Analysis ,Interdisciplinary Communication ,Dermatologic Agents ,business ,Program Evaluation - Abstract
Background: A 6-week personalized integrative multidisciplinary treatment programme (PIM) was developed for children with difficult to treat AD who appeared unresponsive to treatment according to current guidelines. Objective: The aim of the present study was to identify clinical and psychosocial characteristics that predict long-term treatment success after PIM. Methods: Treatment was considered successful when there was a 75% reduction on the Self-Administered Eczema Area and Severity Index and/or little impact of AD on daily life, measured with the Children's Dermatology Life Quality Index (score ≤ 6), 6 months after the end of PIM. PIM is a personalized, integrative, multidisciplinary treatment programme with clearly defined goals and strategies, addressing atopic, paediatric, mental health comorbidities and general well-being, for children and adolescents aged 8- to 18 years. Multivariate logistic regression models were constructed using a backward selection procedure. Questionnaires were used to assess psychosocial characteristics; clinical data was extracted from medical records. Results: In total, 79 children/adolescents with difficult to treat AD completed PIM and long-term treatment results were available for 74 children/adolescents. The majority (77%) of children/adolescents demonstrated long-term treatment success with PIM. Predictors of long-term treatment success (adjusted ORs) included maternal disease acceptance OR (95% CI) 1.84 (1.15–2.94). A group (23%) of mostly females OR (95% CI) 0.10 (0.02–0.54) with multiple somatic complaints OR (95% CI) 0.88(0.80–0.97), from families where the mother has anxiety for the use of topical corticosteroids OR (95% CI) 0.62(0.40–0.94), is less likely to obtain long-term treatment success. Conclusion: Most children and adolescents with difficult to treat AD, seemingly unresponsive to conventional treatment according to current guidelines, are able to improve with PIM. Psychosocial and family but not clinical variables, predicted long-term treatment success after participating in PIM.
- Published
- 2019